Tobin AJ - Search Results

1

Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Menalled LB, Patry M, Ragland N, Lowden PA, Goodman J, Minnich J, Zahasky B, Park L, Leeds J, Howland D, Signer E, Tobin AJ, Brunner D. Menalled LB, et al. Among authors: tobin aj. PLoS One. 2010 Mar 22;5(3):e9793. doi: 10.1371/journal.pone.0009793. PLoS One. 2010. PMID: 20339553 Free PMC article.

2

Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.

Menalled L, El-Khodor BF, Patry M, Suárez-Fariñas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, Signer E, Tobin A, Brunner D. Menalled L, et al. Among authors: tobin a. Neurobiol Dis. 2009 Sep;35(3):319-36. doi: 10.1016/j.nbd.2009.05.007. Epub 2009 May 21. Neurobiol Dis. 2009. PMID: 19464370 Free PMC article.

3

Huntington's disease: the challenge for cell biologists.

Tobin AJ, Signer ER. Tobin AJ, et al. Trends Cell Biol. 2000 Dec;10(12):531-6. doi: 10.1016/s0962-8924(00)01853-5. Trends Cell Biol. 2000. PMID: 11121745 Review.

4

GABA signalling: therapeutic targets for epilepsy, Parkinson's disease and Huntington's disease.

Kleppner SR, Tobin AJ. Kleppner SR, et al. Among authors: tobin aj. Expert Opin Ther Targets. 2001 Apr;5(2):219-39. doi: 10.1517/14728222.5.2.219. Expert Opin Ther Targets. 2001. PMID: 15992178

5

A cell-based screen for drugs to treat Huntington's disease.

Aiken CT, Tobin AJ, Schweitzer ES. Aiken CT, et al. Among authors: tobin aj. Neurobiol Dis. 2004 Aug;16(3):546-55. doi: 10.1016/j.nbd.2004.04.001. Neurobiol Dis. 2004. PMID: 15262266

6

Presence of calbindin D28K and GAD67 mRNAs in both orthotopic and ectopic Purkinje cells of staggerer mice suggests that staggerer acts after the onset of cytodifferentiation.

Frantz GD, Wuenschell CW, Messer A, Tobin AJ. Frantz GD, et al. Among authors: tobin aj. J Neurosci Res. 1996 May 1;44(3):255-62. doi: 10.1002/(SICI)1097-4547(19960501)44:3<255::AID-JNR6>3.0.CO;2-F. J Neurosci Res. 1996. PMID: 8723764

7

Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.

Alexi T, Hughes PE, Knüsel B, Tobin AJ. Alexi T, et al. Among authors: tobin aj. Exp Neurol. 1998 Sep;153(1):74-93. doi: 10.1006/exnr.1998.6842. Exp Neurol. 1998. PMID: 9743569

8

Uniqueness and redundancy in GABA production.

Pinal CS, Tobin AJ. Pinal CS, et al. Among authors: tobin aj. Perspect Dev Neurobiol. 1998;5(2-3):109-18. Perspect Dev Neurobiol. 1998. PMID: 9777629 Review.

9

Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines.

Mi J, Chatterjee S, Wong KK, Forbes C, Lawless G, Tobin AJ. Mi J, et al. Among authors: tobin aj. J Neurosci Res. 1999 Jul 1;57(1):137-48. doi: 10.1002/(SICI)1097-4547(19990701)57:1<137::AID-JNR15>3.0.CO;2-D. J Neurosci Res. 1999. PMID: 10397644

10

Glutamate decarboxylases and autoimmunity in insulin-dependent diabetes.

Kaufman DL, Tobin AJ. Kaufman DL, et al. Among authors: tobin aj. Trends Pharmacol Sci. 1993 Apr;14(4):107-9. doi: 10.1016/0165-6147(93)90079-y. Trends Pharmacol Sci. 1993. PMID: 8516952 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page